RNS Number : 9793W
Marks & Spencer Group PLC
06 August 2018

Director/PDMR Shareholding

Marks and Spencer Group plc (the 'Company') announces that on 6 August 2018 it was notified of the following transactions in the Company's Ordinary 25p shares undertaken by directors / persons discharging managerial responsibility ('PDMRs').

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

A Mellor

2

Reason for the notification

a)

Position/status

PDMR (Group Secretary and Head of Corporate Governance)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marks and Spencer Group plc

b)

LEI

213800EJP14A79ZG1X44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 25p shares

ISIN: GB0031274896

b)

Nature of the transaction

Exercise of options from the 2015 Performance Share Plan (PSP) and 2015 Deferred Share Bonus Plan (DSBP) and sale of sufficient shares to cover the tax and NI liability, with the balance retained.

c)

Price(s) and volume(s)

Scheme

Price(s)

Volume(s)

2015 PSP

�3.096944

4,684

2015 DSBP

�3.096944

9,659

d)

Aggregated information

(volume, price)

Acquired

Sold

Price

Retained

30,408

14,343

�3.096944

16,065

e)

Date of the transaction

2018-07-31

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHQQLFBVVFFBBX